Content Type: Research Publications

Reimagining Pharmaceutical Market Exclusivities: Should the Duration of Guaranteed Monopoly Periods Be Value Based?

March 15, 2026

International Reference Pricing for Prescription Drugs: A Landscape Analysis

March 15, 2026

Controversy Over Using Quality-Adjusted Life-Years in Cost-Effectiveness Analyses: A Systematic Literature Review

March 15, 2026

Regulatory and Clinical Consequences of Negative Confirmatory Trials of Accelerated Approval Cancer Drugs: Retrospective Observational Study

March 15, 2026

Analysis of Launch and Postapproval Cancer Drug Pricing, Clinical Benefit, and Policy Implications in the US and Europe

March 15, 2026

Cost to Medicare of Delayed Adalimumab Biosimilar Availability

March 15, 2026

Assessing the Impact of US Food and Drug Administration Breakthrough Therapy Designation Timing on Trial Characteristics and Development Speed

March 15, 2026

Influenza Vaccine Uptake in the Year After Concurrent vs Separate Influenza and Zoster Immunization

March 15, 2026

Comparing Onset of Biosimilar Versus Generic Competition in the United States

March 15, 2026

Diabetes Drugs: List Price Increases Were Not Always Reflected in Net Price; Impact of Brand Competition Unclear

March 15, 2026

Public Funding for Transformative Drugs: The Case of Sofosbuvir

March 15, 2026

Correlation Between Changes in Brand-Name Drug Prices and Patient Out-Of-Pocket Costs

March 15, 2026